SEC 13F Intelligence

Citadel Investment Advisory, Inc. / ABBV

Citadel Investment Advisory, Inc.’s Abbvie Inc Position

Does Citadel Investment Advisory, Inc. own Abbvie Inc (ABBV)? Yes — 17.9K shares worth $4M (+1.85% of its 13F portfolio) as of Q1 2026, down from 18.3K shares the prior filed quarter.

Position Value
$4M
Q1 2026
Shares
17.9K
% of Portfolio
+1.85%
Quarters Held
22
currently held

Position History ABBV

Reported value by quarter
Q4 ’20: $690,000Q4 ’20Q1 ’21: $2MQ2 ’21: $2MQ3 ’21: $2MQ3 ’21Q4 ’21: $2MQ1 ’22: $3MQ2 ’22: $3MQ2 ’22Q3 ’22: $2MQ4 ’22: $3MQ1 ’23: $3MQ1 ’23Q2 ’23: $2MQ3 ’23: $2MQ4 ’23: $2MQ4 ’23Q1 ’24: $3MQ2 ’24: $3MQ3 ’24: $3MQ3 ’24Q4 ’24: $3MQ1 ’25: $4MQ2 ’25: $3MQ2 ’25Q3 ’25: $4MQ4 ’25: $4MQ1 ’26: $4MQ1 ’26filingsflow.com
QuarterSharesValue% of Portfolio
Q1 202617.9K$4M+1.85%
Q4 202518.3K$4M+1.81%
Q3 202518.3K$4M+1.94%
Q2 202518.3K$3M+1.65%
Q1 202518.5K$4M+1.90%
Q4 202418.4K$3M+1.69%
Q3 202416.2K$3M+1.69%
Q2 202415.8K$3M+1.55%
Q1 202415.8K$3M+1.63%
Q4 202316.1K$2M+1.53%
Q3 202316.1K$2M+1.57%
Q2 202316.1K$2M+1.40%
Q1 202316.4K$3M+1.78%
Q4 202216.8K$3M+1.85%
Q3 202216.9K$2M+1.73%
Q2 202216.7K$3M+1.74%
Q1 202217.3K$3M+1.63%
Q4 202117.6K$2M+1.39%
Q3 202117.6K$2M+1.18%
Q2 202117.6K$2M+1.22%
Q1 202117.9K$2M+1.27%
Q4 20206.4K$690,000+0.49%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Citadel Investment Advisory, Inc.’s full portfolio or all institutional holders of ABBV.